Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi A Madan

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
American Journal of Therapeutics|February 15, 2011
Therapeutic cancer vaccines: the latest advancement in targeted therapyMarijo Bilusic, Ravi A Madan
Expert Review of Vaccines|February 19, 2016
Therapeutic vaccines for prostate cancer: recent advances and future directionsJulius Strauss, Ravi A Madan
The Journal of Clinical Investigation|November 1, 2022
Deciphering the enigma of neuroendocrine prostate cancerFatima Karzai, Ravi A Madan
Nature Cancer|February 5, 2022
Behind the IL-8 ball in prostate cancerRavi A Madan, Claudia Palena
Current Oncology Reports|August 16, 2015
Integrating Immunotherapies in Prostate CancerJulius Strauss, Ravi A Madan
Clinical Genitourinary Cancer|January 7, 2011
The current and emerging role of immunotherapy in prostate cancerRavi A Madan, James L Gulley
Expert Review of Vaccines|November 13, 2015
Prospects for the future of prostate cancer vaccinesRavi A Madan, James L Gulley
Idrugs : the Investigational Drugs Journal|December 24, 2005
Abiraterone. Cougar BiotechnologyRavi A Madan, Philip M Arlen
Asian Journal of Urology|December 22, 2017
Developing immunotherapy strategies in the treatment of prostate cancerJames L Gulley, Ravi A Madan
Nature Reviews. Urology|June 17, 2015
Prostate cancer: Charting a course in metastatic castration-sensitive prostate cancerRavi A Madan, William L Dahut
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
American Journal of Therapeutics|February 15, 2011
Therapeutic cancer vaccines: the latest advancement in targeted therapyMarijo Bilusic, Ravi A Madan
Expert Review of Vaccines|February 19, 2016
Therapeutic vaccines for prostate cancer: recent advances and future directionsJulius Strauss, Ravi A Madan
The Journal of Clinical Investigation|November 1, 2022
Deciphering the enigma of neuroendocrine prostate cancerFatima Karzai, Ravi A Madan
Nature Cancer|February 5, 2022
Behind the IL-8 ball in prostate cancerRavi A Madan, Claudia Palena
Current Oncology Reports|August 16, 2015
Integrating Immunotherapies in Prostate CancerJulius Strauss, Ravi A Madan
Clinical Genitourinary Cancer|January 7, 2011
The current and emerging role of immunotherapy in prostate cancerRavi A Madan, James L Gulley
Expert Review of Vaccines|November 13, 2015
Prospects for the future of prostate cancer vaccinesRavi A Madan, James L Gulley
Idrugs : the Investigational Drugs Journal|December 24, 2005
Abiraterone. Cougar BiotechnologyRavi A Madan, Philip M Arlen
Asian Journal of Urology|December 22, 2017
Developing immunotherapy strategies in the treatment of prostate cancerJames L Gulley, Ravi A Madan
Nature Reviews. Urology|June 17, 2015
Prostate cancer: Charting a course in metastatic castration-sensitive prostate cancerRavi A Madan, William L Dahut
Pageof 21